Posted in | News | Medical Robotics

Hansen Medical to Showcase Magellan Robotic System at International Endovascular Therapy Symposium

Hansen Medical, Inc., a global leader in intravascular robotics, today announced it will exhibit its Magellan™ Robotic System at the 25th Annual International Symposium on Endovascular Therapy (ISET), from January 19-23 at the Fontainebleau Miami Beach Hotel in Miami, FL. The Company will be exhibiting the Magellan Robotic System at Booth 509.

Additionally, Dr. Barry Katzen, founder and Medical Director of Baptist Cardiac & Vascular Institute (Baptist Hospital of Miami), and a course director at ISET, is scheduled to feature the Magellan System in live cases at the conference.

"We are pleased that our Magellan Robotic System will be highlighted at ISET, which is in its 25th year of bringing together interventional cardiologists, vascular surgeons and other healthcare professionals to focus on acquiring the latest knowledge and product information related to interventional medicine and vascular disease," said Bruce Barclay, president and CEO of Hansen Medical. "The live cases scheduled to be performed by Dr. Katzen will provide additional opportunities for clinicians to view the significant clinical benefits provided by the Magellan System. We continue to have growing pipeline of commercial interest in our technology and look forward to further building on this momentum at ISET."

About the Magellan™ Robotic System
Hansen Medical's Magellan Robotic System is based upon the flexible robotic technology incorporated in the Sensei X® Robotic Catheter System currently sold in the U.S. and Europe, which has been used in nearly 10,000 patients, but includes a number of key enhancements. In particular, the Magellan Robotic System:

  • Provides solid catheter stability for placement of therapeutic devices.
  • Is designed to enable predictable procedure times and increased case throughput.
  • Allows for independent, individual robotic control of the distal tips of both the outer sheath and the inner leader catheter, as well as robotic manipulation of standard guidewires.
  • Is designed to allow for sufficient extension inside the body to access hard to reach peripheral anatomy.
  • Preserves the open architecture featured in the Sensei System to allow for the subsequent use of many 6F therapeutic devices on the market today.
  • Is designed to potentially reduce physician radiation exposure and fatigue by employing a remote physician workstation.

Source: http://www.hansenmedical.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Auris Surgical Robotics Inc.. (2019, February 20). Hansen Medical to Showcase Magellan Robotic System at International Endovascular Therapy Symposium. AZoRobotics. Retrieved on May 22, 2024 from https://www.azorobotics.com/News.aspx?newsID=3638.

  • MLA

    Auris Surgical Robotics Inc.. "Hansen Medical to Showcase Magellan Robotic System at International Endovascular Therapy Symposium". AZoRobotics. 22 May 2024. <https://www.azorobotics.com/News.aspx?newsID=3638>.

  • Chicago

    Auris Surgical Robotics Inc.. "Hansen Medical to Showcase Magellan Robotic System at International Endovascular Therapy Symposium". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=3638. (accessed May 22, 2024).

  • Harvard

    Auris Surgical Robotics Inc.. 2019. Hansen Medical to Showcase Magellan Robotic System at International Endovascular Therapy Symposium. AZoRobotics, viewed 22 May 2024, https://www.azorobotics.com/News.aspx?newsID=3638.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.